Tacrine approved for cognitive deficits in Alzheimer's disease.
D000544:Alzheimer Disease / Q000150:complications*; D003072:Cognition Disorders / Q000188:drug therapy* / Q000209:etiology*; D016527:Drug Costs; D006801:Humans; D013619:Tacrine / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use*
D013619:Tacrine